Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) — Working Capital to Net Assets Ratio
Chunghwa Chemical Synthesis & Biotech Co Ltd (1762) has a Working Capital to Net Assets ratio of 22.7% as of December 2025. Working capital of NT$702.18 Million (current assets of NT$1.06 Billion minus current liabilities of NT$356.71 Million) is measured against net assets of NT$3.09 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Chunghwa Chemical Synthesis & Biotech Co balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Chunghwa Chemical Synthesis & Biotech Co Ltd Working Capital to Net Assets (2009–2025)
This chart shows how Chunghwa Chemical Synthesis & Biotech Co Ltd's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the ratio stands at 22.7%, reflecting working capital of NT$702.18 Million against net assets of NT$3.09 Billion TWD. Check 1762 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Chunghwa Chemical Synthesis & Biotech Co Ltd (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Chunghwa Chemical Synthesis & Biotech Co Ltd from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 1762 market cap.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 22.7% | NT$702.18 Million | NT$3.09 Billion | NT$1.06 Billion | NT$356.71 Million | ▼ -7.5 pp |
| 2024 | 30.3% | NT$1.02 Billion | NT$3.36 Billion | NT$1.44 Billion | NT$425.29 Million | ▲ +1.7 pp |
| 2023 | 28.5% | NT$956.37 Million | NT$3.35 Billion | NT$1.79 Billion | NT$831.41 Million | ▲ +2.4 pp |
| 2022 | 26.1% | NT$834.81 Million | NT$3.19 Billion | NT$1.45 Billion | NT$614.18 Million | ▲ +1.2 pp |
| 2021 | 24.9% | NT$721.91 Million | NT$2.89 Billion | NT$1.36 Billion | NT$635.17 Million | ▲ +0.9 pp |
| 2020 | 24.1% | NT$601.44 Million | NT$2.50 Billion | NT$1.00 Billion | NT$400.16 Million | ▲ +18.6 pp |
| 2019 | 5.5% | NT$111.16 Million | NT$2.02 Billion | NT$687.58 Million | NT$576.42 Million | ▼ -4.0 pp |
| 2018 | 9.5% | NT$188.10 Million | NT$1.98 Billion | NT$613.79 Million | NT$425.69 Million | ▼ -2.5 pp |
| 2017 | 12.0% | NT$218.81 Million | NT$1.82 Billion | NT$1.03 Billion | NT$808.31 Million | ▲ +5.4 pp |
| 2016 | 6.6% | NT$117.21 Million | NT$1.77 Billion | NT$728.77 Million | NT$611.56 Million | ▼ -5.7 pp |
| 2015 | 12.3% | NT$229.39 Million | NT$1.86 Billion | NT$864.49 Million | NT$635.10 Million | ▼ -21.2 pp |
| 2014 | 33.5% | NT$540.90 Million | NT$1.62 Billion | NT$1.24 Billion | NT$696.09 Million | ▲ +25.5 pp |
| 2013 | 8.0% | NT$136.23 Million | NT$1.71 Billion | NT$667.37 Million | NT$531.14 Million | ▲ +1.8 pp |
| 2012 | 6.1% | NT$103.00 Million | NT$1.68 Billion | NT$679.33 Million | NT$576.33 Million | ▼ -13.1 pp |
| 2011 | 19.3% | NT$323.45 Million | NT$1.68 Billion | NT$768.55 Million | NT$445.10 Million | ▼ -1.0 pp |
| 2010 | 20.3% | NT$341.83 Million | NT$1.68 Billion | NT$758.58 Million | NT$416.75 Million | ▲ +14.7 pp |
| 2009 | 5.6% | NT$67.31 Million | NT$1.19 Billion | NT$655.85 Million | NT$588.54 Million | — |